Q2 2026 Holdings
Filed 2026-08-14 | 120 holdings | $1.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & Co(LLY) | COM | 532457108 | $24.1M | 20,116 | 1.3% |
| Chemed Corp New(CHE) | COM | 16359R103 | $24.5M | 52,523 | 1.3% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $25.3M | 481,833 | 1.3% |
| Community Health SYS Inc New(CYH) | COM | 203668108 | $26.3M | 7,864,575 | 1.4% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $34.2M | 428,652 | 1.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $36.6M | 629,952 | 1.9% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $38.3M | 98,252 | 2.0% |
| Caretrust REIT Inc(CTRE) | COM | 14174T107 | $43.3M | 1,072,015 | 2.2% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $45.4M | 798,973 | 2.4% |
| Natera Inc(NTRA) | COM | 632307104 | $47.7M | 175,807 | 2.5% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $52.7M | 664,684 | 2.7% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $54.6M | 3,396,470 | 2.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $61.2M | 2,798,210 | 3.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $66.5M | 1,785,941 | 3.4% |
| Invesco QQQ TR(QQQ)Put | UNIT SER 1 | 46090E103 | $72.6M | 98,600 | 3.8% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $94.9M | 2,212,770 | 4.9% |
| Ensign Group Inc(ENSG) | COM | 29358P101 | $96.5M | 602,079 | 5.0% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $103.8M | 1,026,919 | 5.4% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $121.8M | 913,880 | 6.3% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $155.9M | 287,668 | 8.1% |